deltatrials
Completed NA NCT04947436

ALS and Airway Clearance (ALSAC) Therapy

ALS and Airway Clearance (ALSAC) Is There a Best Therapy for Airway Clearance in Patients With ALS

Sponsor: ALS Association

Updated 4 times since 2021 Last updated: Oct 6, 2021 Started: Jan 25, 2012 Primary completion: Sep 21, 2016 Completion: Sep 17, 2017

A NA clinical study on Amyotrophic Lateral Sclerosis and Respiratory Muscle Weakness, this trial is completed. The trial is conducted by ALS Association and has accumulated 4 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2021 — Jul 2024 [monthly]

    Completed NA

  4. Sep 2021 — Dec 2021 [monthly]

    Completed NA

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ALS Association
  • The University of Texas Health Science Center at San Antonio
Data source: The University of Texas Health Science Center at San Antonio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations